nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0753	0.104	CbGbCtD
Tolvaptan—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.057	0.0788	CbGbCtD
Tolvaptan—ABCB1—Betamethasone—systemic lupus erythematosus	0.0489	0.0676	CbGbCtD
Tolvaptan—ABCB1—Prednisolone—systemic lupus erythematosus	0.0483	0.0667	CbGbCtD
Tolvaptan—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0458	0.0632	CbGbCtD
Tolvaptan—ABCB1—Prednisone—systemic lupus erythematosus	0.0456	0.063	CbGbCtD
Tolvaptan—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0451	0.0623	CbGbCtD
Tolvaptan—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0432	0.0597	CbGbCtD
Tolvaptan—CYP3A4—Dapsone—systemic lupus erythematosus	0.0394	0.0544	CbGbCtD
Tolvaptan—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0342	0.0472	CbGbCtD
Tolvaptan—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0342	0.0472	CbGbCtD
Tolvaptan—AVPR2—urine—systemic lupus erythematosus	0.0323	0.344	CbGeAlD
Tolvaptan—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0293	0.0405	CbGbCtD
Tolvaptan—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0289	0.0399	CbGbCtD
Tolvaptan—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0285	0.0393	CbGbCtD
Tolvaptan—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0274	0.0379	CbGbCtD
Tolvaptan—CYP3A4—Prednisone—systemic lupus erythematosus	0.0273	0.0377	CbGbCtD
Tolvaptan—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0259	0.0358	CbGbCtD
Tolvaptan—ABCB1—Methotrexate—systemic lupus erythematosus	0.0229	0.0316	CbGbCtD
Tolvaptan—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0171	0.0236	CbGbCtD
Tolvaptan—AVPR2—nephron tubule—systemic lupus erythematosus	0.00869	0.0927	CbGeAlD
Tolvaptan—AVPR2—kidney—systemic lupus erythematosus	0.00764	0.0815	CbGeAlD
Tolvaptan—AVPR1A—lung—systemic lupus erythematosus	0.00653	0.0697	CbGeAlD
Tolvaptan—AVPR1A—central nervous system—systemic lupus erythematosus	0.00582	0.0621	CbGeAlD
Tolvaptan—AVPR2—lung—systemic lupus erythematosus	0.00541	0.0577	CbGeAlD
Tolvaptan—AVPR2—nervous system—systemic lupus erythematosus	0.00501	0.0535	CbGeAlD
Tolvaptan—CYP3A4—urine—systemic lupus erythematosus	0.00492	0.0524	CbGeAlD
Tolvaptan—AVPR2—central nervous system—systemic lupus erythematosus	0.00483	0.0515	CbGeAlD
Tolvaptan—CYP3A4—blood plasma—systemic lupus erythematosus	0.00257	0.0274	CbGeAlD
Tolvaptan—ABCB1—blood plasma—systemic lupus erythematosus	0.00182	0.0194	CbGeAlD
Tolvaptan—CYP3A4—kidney—systemic lupus erythematosus	0.00116	0.0124	CbGeAlD
Tolvaptan—ABCB1—nephron tubule—systemic lupus erythematosus	0.000937	0.00999	CbGeAlD
Tolvaptan—ABCB1—kidney—systemic lupus erythematosus	0.000823	0.00878	CbGeAlD
Tolvaptan—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000802	0.00855	CbGeAlD
Tolvaptan—CYP3A4—nervous system—systemic lupus erythematosus	0.000763	0.00814	CbGeAlD
Tolvaptan—CYP3A4—central nervous system—systemic lupus erythematosus	0.000735	0.00784	CbGeAlD
Tolvaptan—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000707	0.00754	CbGeAlD
Tolvaptan—ABCB1—bone marrow—systemic lupus erythematosus	0.000644	0.00687	CbGeAlD
Tolvaptan—ABCB1—lung—systemic lupus erythematosus	0.000583	0.00622	CbGeAlD
Tolvaptan—Angiopathy—Mycophenolate mofetil—systemic lupus erythematosus	0.000541	0.00303	CcSEcCtD
Tolvaptan—ABCB1—nervous system—systemic lupus erythematosus	0.00054	0.00576	CbGeAlD
Tolvaptan—Mediastinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000538	0.00301	CcSEcCtD
Tolvaptan—Anorexia—Leflunomide—systemic lupus erythematosus	0.000537	0.00301	CcSEcCtD
Tolvaptan—Connective tissue disorder—Hydrocortisone—systemic lupus erythematosus	0.000534	0.00299	CcSEcCtD
Tolvaptan—Malnutrition—Cyclosporine—systemic lupus erythematosus	0.000532	0.00298	CcSEcCtD
Tolvaptan—Hyperglycaemia—Dexamethasone—systemic lupus erythematosus	0.000523	0.00293	CcSEcCtD
Tolvaptan—Hyperglycaemia—Betamethasone—systemic lupus erythematosus	0.000523	0.00293	CcSEcCtD
Tolvaptan—Dysgeusia—Cyclosporine—systemic lupus erythematosus	0.000521	0.00292	CcSEcCtD
Tolvaptan—ABCB1—central nervous system—systemic lupus erythematosus	0.00052	0.00555	CbGeAlD
Tolvaptan—Malnutrition—Mycophenolate mofetil—systemic lupus erythematosus	0.000519	0.00291	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Prednisone—systemic lupus erythematosus	0.000516	0.00289	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000515	0.00288	CcSEcCtD
Tolvaptan—Dysgeusia—Mycophenolate mofetil—systemic lupus erythematosus	0.000509	0.00285	CcSEcCtD
Tolvaptan—Connective tissue disorder—Methylprednisolone—systemic lupus erythematosus	0.000502	0.00281	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Methotrexate—systemic lupus erythematosus	0.000499	0.00279	CcSEcCtD
Tolvaptan—Ill-defined disorder—Cyclosporine—systemic lupus erythematosus	0.000494	0.00277	CcSEcCtD
Tolvaptan—Feeling abnormal—Azathioprine—systemic lupus erythematosus	0.000491	0.00275	CcSEcCtD
Tolvaptan—Immune system disorder—Hydrocortisone—systemic lupus erythematosus	0.000491	0.00275	CcSEcCtD
Tolvaptan—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.000489	0.00274	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000486	0.00272	CcSEcCtD
Tolvaptan—Ill-defined disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000482	0.0027	CcSEcCtD
Tolvaptan—Constipation—Leflunomide—systemic lupus erythematosus	0.000481	0.0027	CcSEcCtD
Tolvaptan—Malaise—Cyclosporine—systemic lupus erythematosus	0.00048	0.00269	CcSEcCtD
Tolvaptan—Cardiac disorder—Methylprednisolone—systemic lupus erythematosus	0.000474	0.00266	CcSEcCtD
Tolvaptan—Malnutrition—Hydrocortisone—systemic lupus erythematosus	0.000473	0.00265	CcSEcCtD
Tolvaptan—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.000471	0.00264	CcSEcCtD
Tolvaptan—Malaise—Mycophenolate mofetil—systemic lupus erythematosus	0.000468	0.00262	CcSEcCtD
Tolvaptan—Syncope—Mycophenolate mofetil—systemic lupus erythematosus	0.000466	0.00261	CcSEcCtD
Tolvaptan—Feeling abnormal—Leflunomide—systemic lupus erythematosus	0.000464	0.0026	CcSEcCtD
Tolvaptan—Angiopathy—Methylprednisolone—systemic lupus erythematosus	0.000463	0.0026	CcSEcCtD
Tolvaptan—Immune system disorder—Methylprednisolone—systemic lupus erythematosus	0.000461	0.00258	CcSEcCtD
Tolvaptan—Mediastinal disorder—Methylprednisolone—systemic lupus erythematosus	0.00046	0.00258	CcSEcCtD
Tolvaptan—Loss of consciousness—Mycophenolate mofetil—systemic lupus erythematosus	0.000456	0.00256	CcSEcCtD
Tolvaptan—Hyperglycaemia—Prednisone—systemic lupus erythematosus	0.000456	0.00255	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.00045	0.00252	CcSEcCtD
Tolvaptan—Ill-defined disorder—Prednisolone—systemic lupus erythematosus	0.000449	0.00252	CcSEcCtD
Tolvaptan—Discomfort—Cyclosporine—systemic lupus erythematosus	0.000448	0.00251	CcSEcCtD
Tolvaptan—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.000445	0.00249	CcSEcCtD
Tolvaptan—Malnutrition—Methylprednisolone—systemic lupus erythematosus	0.000445	0.00249	CcSEcCtD
Tolvaptan—Dry mouth—Cyclosporine—systemic lupus erythematosus	0.000443	0.00248	CcSEcCtD
Tolvaptan—Breast disorder—Methotrexate—systemic lupus erythematosus	0.000441	0.00247	CcSEcCtD
Tolvaptan—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.000439	0.00246	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000439	0.00246	CcSEcCtD
Tolvaptan—Ill-defined disorder—Hydrocortisone—systemic lupus erythematosus	0.000439	0.00246	CcSEcCtD
Tolvaptan—Malaise—Prednisolone—systemic lupus erythematosus	0.000437	0.00245	CcSEcCtD
Tolvaptan—Discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000437	0.00245	CcSEcCtD
Tolvaptan—Dysgeusia—Triamcinolone—systemic lupus erythematosus	0.000436	0.00244	CcSEcCtD
Tolvaptan—Anaphylactic shock—Cyclosporine—systemic lupus erythematosus	0.000435	0.00243	CcSEcCtD
Tolvaptan—Syncope—Prednisolone—systemic lupus erythematosus	0.000434	0.00243	CcSEcCtD
Tolvaptan—Dry mouth—Mycophenolate mofetil—systemic lupus erythematosus	0.000432	0.00242	CcSEcCtD
Tolvaptan—Malaise—Hydrocortisone—systemic lupus erythematosus	0.000427	0.00239	CcSEcCtD
Tolvaptan—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000426	0.00239	CcSEcCtD
Tolvaptan—Loss of consciousness—Prednisolone—systemic lupus erythematosus	0.000426	0.00239	CcSEcCtD
Tolvaptan—Syncope—Hydrocortisone—systemic lupus erythematosus	0.000424	0.00238	CcSEcCtD
Tolvaptan—Anaphylactic shock—Mycophenolate mofetil—systemic lupus erythematosus	0.000424	0.00237	CcSEcCtD
Tolvaptan—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000422	0.00236	CcSEcCtD
Tolvaptan—Angiopathy—Dexamethasone—systemic lupus erythematosus	0.000421	0.00236	CcSEcCtD
Tolvaptan—Angiopathy—Betamethasone—systemic lupus erythematosus	0.000421	0.00236	CcSEcCtD
Tolvaptan—Shock—Mycophenolate mofetil—systemic lupus erythematosus	0.000417	0.00234	CcSEcCtD
Tolvaptan—Loss of consciousness—Hydrocortisone—systemic lupus erythematosus	0.000416	0.00233	CcSEcCtD
Tolvaptan—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000416	0.00233	CcSEcCtD
Tolvaptan—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000415	0.00232	CcSEcCtD
Tolvaptan—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000414	0.00232	CcSEcCtD
Tolvaptan—Ill-defined disorder—Triamcinolone—systemic lupus erythematosus	0.000413	0.00232	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methylprednisolone—systemic lupus erythematosus	0.000412	0.00231	CcSEcCtD
Tolvaptan—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000412	0.00231	CcSEcCtD
Tolvaptan—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000408	0.00229	CcSEcCtD
Tolvaptan—Discomfort—Prednisolone—systemic lupus erythematosus	0.000408	0.00228	CcSEcCtD
Tolvaptan—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000404	0.00226	CcSEcCtD
Tolvaptan—Asthenia—Leflunomide—systemic lupus erythematosus	0.000404	0.00226	CcSEcCtD
Tolvaptan—Malaise—Triamcinolone—systemic lupus erythematosus	0.000402	0.00225	CcSEcCtD
Tolvaptan—Malaise—Methylprednisolone—systemic lupus erythematosus	0.000401	0.00225	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.0004	0.00224	CcSEcCtD
Tolvaptan—Syncope—Triamcinolone—systemic lupus erythematosus	0.0004	0.00224	CcSEcCtD
Tolvaptan—Syncope—Methylprednisolone—systemic lupus erythematosus	0.000399	0.00223	CcSEcCtD
Tolvaptan—Pruritus—Leflunomide—systemic lupus erythematosus	0.000398	0.00223	CcSEcCtD
Tolvaptan—Discomfort—Hydrocortisone—systemic lupus erythematosus	0.000398	0.00223	CcSEcCtD
Tolvaptan—Connective tissue disorder—Prednisone—systemic lupus erythematosus	0.000397	0.00223	CcSEcCtD
Tolvaptan—Anaphylactic shock—Prednisolone—systemic lupus erythematosus	0.000395	0.00222	CcSEcCtD
Tolvaptan—Dizziness—Azathioprine—systemic lupus erythematosus	0.000394	0.00221	CcSEcCtD
Tolvaptan—Loss of consciousness—Triamcinolone—systemic lupus erythematosus	0.000392	0.00219	CcSEcCtD
Tolvaptan—Loss of consciousness—Methylprednisolone—systemic lupus erythematosus	0.000391	0.00219	CcSEcCtD
Tolvaptan—Shock—Prednisolone—systemic lupus erythematosus	0.000389	0.00218	CcSEcCtD
Tolvaptan—Anaphylactic shock—Hydrocortisone—systemic lupus erythematosus	0.000386	0.00216	CcSEcCtD
Tolvaptan—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000385	0.00216	CcSEcCtD
Tolvaptan—Shock—Hydrocortisone—systemic lupus erythematosus	0.00038	0.00213	CcSEcCtD
Tolvaptan—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000379	0.00212	CcSEcCtD
Tolvaptan—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000378	0.00212	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000376	0.00211	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000375	0.0021	CcSEcCtD
Tolvaptan—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000375	0.0021	CcSEcCtD
Tolvaptan—Ill-defined disorder—Betamethasone—systemic lupus erythematosus	0.000375	0.0021	CcSEcCtD
Tolvaptan—Ill-defined disorder—Dexamethasone—systemic lupus erythematosus	0.000375	0.0021	CcSEcCtD
Tolvaptan—Discomfort—Triamcinolone—systemic lupus erythematosus	0.000375	0.0021	CcSEcCtD
Tolvaptan—Discomfort—Methylprednisolone—systemic lupus erythematosus	0.000374	0.00209	CcSEcCtD
Tolvaptan—Headache—Azathioprine—systemic lupus erythematosus	0.000373	0.00209	CcSEcCtD
Tolvaptan—Dizziness—Leflunomide—systemic lupus erythematosus	0.000372	0.00209	CcSEcCtD
Tolvaptan—Constipation—Cyclosporine—systemic lupus erythematosus	0.000372	0.00208	CcSEcCtD
Tolvaptan—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.000371	0.00208	CcSEcCtD
Tolvaptan—Renal failure—Methotrexate—systemic lupus erythematosus	0.00037	0.00207	CcSEcCtD
Tolvaptan—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000368	0.00206	CcSEcCtD
Tolvaptan—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000368	0.00206	CcSEcCtD
Tolvaptan—Angiopathy—Prednisone—systemic lupus erythematosus	0.000367	0.00206	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000366	0.00205	CcSEcCtD
Tolvaptan—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000365	0.00205	CcSEcCtD
Tolvaptan—Malaise—Betamethasone—systemic lupus erythematosus	0.000365	0.00204	CcSEcCtD
Tolvaptan—Malaise—Dexamethasone—systemic lupus erythematosus	0.000365	0.00204	CcSEcCtD
Tolvaptan—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.000364	0.00204	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.000363	0.00203	CcSEcCtD
Tolvaptan—Syncope—Betamethasone—systemic lupus erythematosus	0.000363	0.00203	CcSEcCtD
Tolvaptan—Syncope—Dexamethasone—systemic lupus erythematosus	0.000363	0.00203	CcSEcCtD
Tolvaptan—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000362	0.00203	CcSEcCtD
Tolvaptan—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000358	0.00201	CcSEcCtD
Tolvaptan—Shock—Triamcinolone—systemic lupus erythematosus	0.000358	0.002	CcSEcCtD
Tolvaptan—Shock—Methylprednisolone—systemic lupus erythematosus	0.000357	0.002	CcSEcCtD
Tolvaptan—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000356	0.00199	CcSEcCtD
Tolvaptan—Loss of consciousness—Betamethasone—systemic lupus erythematosus	0.000355	0.00199	CcSEcCtD
Tolvaptan—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	0.000355	0.00199	CcSEcCtD
Tolvaptan—Nausea—Azathioprine—systemic lupus erythematosus	0.000354	0.00198	CcSEcCtD
Tolvaptan—Headache—Leflunomide—systemic lupus erythematosus	0.000353	0.00198	CcSEcCtD
Tolvaptan—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000352	0.00197	CcSEcCtD
Tolvaptan—Malnutrition—Prednisone—systemic lupus erythematosus	0.000352	0.00197	CcSEcCtD
Tolvaptan—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000349	0.00196	CcSEcCtD
Tolvaptan—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000343	0.00192	CcSEcCtD
Tolvaptan—Discomfort—Betamethasone—systemic lupus erythematosus	0.00034	0.00191	CcSEcCtD
Tolvaptan—Discomfort—Dexamethasone—systemic lupus erythematosus	0.00034	0.00191	CcSEcCtD
Tolvaptan—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000336	0.00188	CcSEcCtD
Tolvaptan—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000335	0.00188	CcSEcCtD
Tolvaptan—Nausea—Leflunomide—systemic lupus erythematosus	0.000334	0.00187	CcSEcCtD
Tolvaptan—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000334	0.00187	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000333	0.00187	CcSEcCtD
Tolvaptan—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000331	0.00186	CcSEcCtD
Tolvaptan—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.00033	0.00185	CcSEcCtD
Tolvaptan—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.00033	0.00185	CcSEcCtD
Tolvaptan—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000327	0.00183	CcSEcCtD
Tolvaptan—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000326	0.00183	CcSEcCtD
Tolvaptan—Shock—Betamethasone—systemic lupus erythematosus	0.000325	0.00182	CcSEcCtD
Tolvaptan—Shock—Dexamethasone—systemic lupus erythematosus	0.000325	0.00182	CcSEcCtD
Tolvaptan—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000324	0.00181	CcSEcCtD
Tolvaptan—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000324	0.00181	CcSEcCtD
Tolvaptan—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.00032	0.00179	CcSEcCtD
Tolvaptan—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000318	0.00178	CcSEcCtD
Tolvaptan—Malaise—Prednisone—systemic lupus erythematosus	0.000317	0.00178	CcSEcCtD
Tolvaptan—Syncope—Prednisone—systemic lupus erythematosus	0.000316	0.00177	CcSEcCtD
Tolvaptan—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000314	0.00176	CcSEcCtD
Tolvaptan—Anorexia—Betamethasone—systemic lupus erythematosus	0.000314	0.00176	CcSEcCtD
Tolvaptan—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000314	0.00176	CcSEcCtD
Tolvaptan—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000312	0.00175	CcSEcCtD
Tolvaptan—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000312	0.00175	CcSEcCtD
Tolvaptan—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000309	0.00173	CcSEcCtD
Tolvaptan—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000307	0.00172	CcSEcCtD
Tolvaptan—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000307	0.00172	CcSEcCtD
Tolvaptan—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000305	0.00171	CcSEcCtD
Tolvaptan—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000305	0.00171	CcSEcCtD
Tolvaptan—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000305	0.00171	CcSEcCtD
Tolvaptan—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000304	0.0017	CcSEcCtD
Tolvaptan—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.0003	0.00168	CcSEcCtD
Tolvaptan—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.0003	0.00168	CcSEcCtD
Tolvaptan—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000299	0.00167	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000298	0.00167	CcSEcCtD
Tolvaptan—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000297	0.00167	CcSEcCtD
Tolvaptan—Discomfort—Prednisone—systemic lupus erythematosus	0.000296	0.00166	CcSEcCtD
Tolvaptan—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000294	0.00165	CcSEcCtD
Tolvaptan—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000291	0.00163	CcSEcCtD
Tolvaptan—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.00029	0.00162	CcSEcCtD
Tolvaptan—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000288	0.00161	CcSEcCtD
Tolvaptan—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000287	0.00161	CcSEcCtD
Tolvaptan—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000287	0.00161	CcSEcCtD
Tolvaptan—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000287	0.00161	CcSEcCtD
Tolvaptan—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000287	0.00161	CcSEcCtD
Tolvaptan—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000287	0.00161	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000285	0.0016	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000285	0.0016	CcSEcCtD
Tolvaptan—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000285	0.00159	CcSEcCtD
Tolvaptan—Shock—Prednisone—systemic lupus erythematosus	0.000283	0.00158	CcSEcCtD
Tolvaptan—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000282	0.00158	CcSEcCtD
Tolvaptan—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.00028	0.00157	CcSEcCtD
Tolvaptan—Skin disorder—Prednisone—systemic lupus erythematosus	0.000279	0.00156	CcSEcCtD
Tolvaptan—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000277	0.00155	CcSEcCtD
Tolvaptan—Anorexia—Prednisone—systemic lupus erythematosus	0.000274	0.00153	CcSEcCtD
Tolvaptan—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000273	0.00153	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000273	0.00153	CcSEcCtD
Tolvaptan—Headache—Cyclosporine—systemic lupus erythematosus	0.000272	0.00153	CcSEcCtD
Tolvaptan—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000272	0.00152	CcSEcCtD
Tolvaptan—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000272	0.00152	CcSEcCtD
Tolvaptan—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000268	0.0015	CcSEcCtD
Tolvaptan—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000267	0.0015	CcSEcCtD
Tolvaptan—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000266	0.00149	CcSEcCtD
Tolvaptan—Malaise—Methotrexate—systemic lupus erythematosus	0.000265	0.00149	CcSEcCtD
Tolvaptan—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000264	0.00148	CcSEcCtD
Tolvaptan—Dizziness—Prednisolone—systemic lupus erythematosus	0.000261	0.00146	CcSEcCtD
Tolvaptan—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000261	0.00146	CcSEcCtD
Tolvaptan—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000261	0.00146	CcSEcCtD
Tolvaptan—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000261	0.00146	CcSEcCtD
Tolvaptan—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.00026	0.00146	CcSEcCtD
Tolvaptan—Nausea—Cyclosporine—systemic lupus erythematosus	0.000258	0.00145	CcSEcCtD
Tolvaptan—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000257	0.00144	CcSEcCtD
Tolvaptan—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000257	0.00144	CcSEcCtD
Tolvaptan—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000255	0.00143	CcSEcCtD
Tolvaptan—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000252	0.00141	CcSEcCtD
Tolvaptan—Decreased appetite—Prednisone—systemic lupus erythematosus	0.00025	0.0014	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000249	0.00139	CcSEcCtD
Tolvaptan—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000248	0.00139	CcSEcCtD
Tolvaptan—Headache—Prednisolone—systemic lupus erythematosus	0.000248	0.00139	CcSEcCtD
Tolvaptan—Discomfort—Methotrexate—systemic lupus erythematosus	0.000247	0.00139	CcSEcCtD
Tolvaptan—Constipation—Prednisone—systemic lupus erythematosus	0.000246	0.00138	CcSEcCtD
Tolvaptan—Headache—Hydrocortisone—systemic lupus erythematosus	0.000242	0.00136	CcSEcCtD
Tolvaptan—Dizziness—Triamcinolone—systemic lupus erythematosus	0.00024	0.00135	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.00024	0.00135	CcSEcCtD
Tolvaptan—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.00024	0.00134	CcSEcCtD
Tolvaptan—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000237	0.00133	CcSEcCtD
Tolvaptan—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000237	0.00133	CcSEcCtD
Tolvaptan—Asthenia—Betamethasone—systemic lupus erythematosus	0.000237	0.00133	CcSEcCtD
Tolvaptan—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000235	0.00132	CcSEcCtD
Tolvaptan—Nausea—Prednisolone—systemic lupus erythematosus	0.000235	0.00132	CcSEcCtD
Tolvaptan—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000233	0.00131	CcSEcCtD
Tolvaptan—Pruritus—Betamethasone—systemic lupus erythematosus	0.000233	0.00131	CcSEcCtD
Tolvaptan—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000233	0.00131	CcSEcCtD
Tolvaptan—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000229	0.00129	CcSEcCtD
Tolvaptan—Anorexia—Methotrexate—systemic lupus erythematosus	0.000229	0.00128	CcSEcCtD
Tolvaptan—Headache—Triamcinolone—systemic lupus erythematosus	0.000228	0.00128	CcSEcCtD
Tolvaptan—Headache—Methylprednisolone—systemic lupus erythematosus	0.000227	0.00127	CcSEcCtD
Tolvaptan—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000227	0.00127	CcSEcCtD
Tolvaptan—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000226	0.00126	CcSEcCtD
Tolvaptan—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000226	0.00126	CcSEcCtD
Tolvaptan—Dizziness—Betamethasone—systemic lupus erythematosus	0.000218	0.00122	CcSEcCtD
Tolvaptan—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000218	0.00122	CcSEcCtD
Tolvaptan—Nausea—Triamcinolone—systemic lupus erythematosus	0.000216	0.00121	CcSEcCtD
Tolvaptan—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000215	0.00121	CcSEcCtD
Tolvaptan—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000212	0.00119	CcSEcCtD
Tolvaptan—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000209	0.00117	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000207	0.00116	CcSEcCtD
Tolvaptan—Headache—Betamethasone—systemic lupus erythematosus	0.000207	0.00116	CcSEcCtD
Tolvaptan—Headache—Dexamethasone—systemic lupus erythematosus	0.000207	0.00116	CcSEcCtD
Tolvaptan—Asthenia—Prednisone—systemic lupus erythematosus	0.000206	0.00115	CcSEcCtD
Tolvaptan—Pruritus—Prednisone—systemic lupus erythematosus	0.000203	0.00114	CcSEcCtD
Tolvaptan—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000198	0.00111	CcSEcCtD
Tolvaptan—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000197	0.0011	CcSEcCtD
Tolvaptan—Nausea—Dexamethasone—systemic lupus erythematosus	0.000196	0.0011	CcSEcCtD
Tolvaptan—Nausea—Betamethasone—systemic lupus erythematosus	0.000196	0.0011	CcSEcCtD
Tolvaptan—Dizziness—Prednisone—systemic lupus erythematosus	0.00019	0.00106	CcSEcCtD
Tolvaptan—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.00019	0.00106	CcSEcCtD
Tolvaptan—Headache—Prednisone—systemic lupus erythematosus	0.00018	0.00101	CcSEcCtD
Tolvaptan—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000177	0.000991	CcSEcCtD
Tolvaptan—Asthenia—Methotrexate—systemic lupus erythematosus	0.000172	0.000965	CcSEcCtD
Tolvaptan—Nausea—Prednisone—systemic lupus erythematosus	0.000171	0.000956	CcSEcCtD
Tolvaptan—Pruritus—Methotrexate—systemic lupus erythematosus	0.00017	0.000952	CcSEcCtD
Tolvaptan—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000164	0.00092	CcSEcCtD
Tolvaptan—Dizziness—Methotrexate—systemic lupus erythematosus	0.000159	0.00089	CcSEcCtD
Tolvaptan—Headache—Methotrexate—systemic lupus erythematosus	0.00015	0.000843	CcSEcCtD
Tolvaptan—Nausea—Methotrexate—systemic lupus erythematosus	0.000143	0.000799	CcSEcCtD
Tolvaptan—ABCB1—Allograft Rejection—IL21—systemic lupus erythematosus	8.77e-05	0.0239	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide GPCRs—CCR5—systemic lupus erythematosus	8.08e-05	0.022	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide GPCRs—CCR5—systemic lupus erythematosus	8.02e-05	0.0218	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	7.35e-05	0.02	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	6.45e-05	0.0176	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	6.4e-05	0.0174	CbGpPWpGaD
Tolvaptan—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	5.86e-05	0.016	CbGpPWpGaD
Tolvaptan—ABCB1—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	5.63e-05	0.0153	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	5.54e-05	0.0151	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	5.52e-05	0.0151	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	5.5e-05	0.015	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	5.48e-05	0.0149	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	5.23e-05	0.0143	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	4.68e-05	0.0128	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—C4A—systemic lupus erythematosus	4.28e-05	0.0117	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—P2RY12—systemic lupus erythematosus	4.21e-05	0.0115	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—P2RY12—systemic lupus erythematosus	4.18e-05	0.0114	CbGpPWpGaD
Tolvaptan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	3.85e-05	0.0105	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	3.8e-05	0.0104	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	3.77e-05	0.0103	CbGpPWpGaD
Tolvaptan—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	3.75e-05	0.0102	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	3.72e-05	0.0101	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	3.71e-05	0.0101	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	3.69e-05	0.0101	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	3.69e-05	0.01	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	3.63e-05	0.00989	CbGpPWpGaD
Tolvaptan—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	3.5e-05	0.00955	CbGpPWpGaD
Tolvaptan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	3.47e-05	0.00945	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—F2—systemic lupus erythematosus	3.3e-05	0.00899	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	3.26e-05	0.00888	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	3.24e-05	0.00882	CbGpPWpGaD
Tolvaptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	3.23e-05	0.00881	CbGpPWpGaD
Tolvaptan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	3.23e-05	0.00879	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—FOXP3—systemic lupus erythematosus	2.99e-05	0.00816	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	2.98e-05	0.00811	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	2.97e-05	0.0081	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	2.95e-05	0.00805	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	2.95e-05	0.00804	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	2.9e-05	0.00791	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	2.88e-05	0.00786	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CXCL12—systemic lupus erythematosus	2.83e-05	0.00771	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CXCL12—systemic lupus erythematosus	2.81e-05	0.00766	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	2.55e-05	0.00694	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	2.53e-05	0.00689	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	2.49e-05	0.00678	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	2.47e-05	0.00674	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	2.44e-05	0.00665	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	2.39e-05	0.00651	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	2.38e-05	0.00648	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	2.36e-05	0.00643	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL17A—systemic lupus erythematosus	2.36e-05	0.00643	CbGpPWpGaD
Tolvaptan—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	2.31e-05	0.00629	CbGpPWpGaD
Tolvaptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	2.25e-05	0.00614	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	2.19e-05	0.00597	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	2.19e-05	0.00596	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	2.17e-05	0.00591	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—P2RY12—systemic lupus erythematosus	2.16e-05	0.00588	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—P2RY12—systemic lupus erythematosus	2.14e-05	0.00584	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	2.11e-05	0.00576	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	2.09e-05	0.0057	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	2.06e-05	0.00562	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	1.99e-05	0.00543	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	1.95e-05	0.00531	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CCR5—systemic lupus erythematosus	1.94e-05	0.00529	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	1.93e-05	0.00527	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CCR5—systemic lupus erythematosus	1.93e-05	0.00525	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—C3—systemic lupus erythematosus	1.9e-05	0.00517	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—C3—systemic lupus erythematosus	1.88e-05	0.00513	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.87e-05	0.0051	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	1.81e-05	0.00494	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	1.7e-05	0.00463	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—F2—systemic lupus erythematosus	1.66e-05	0.00454	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—F2—systemic lupus erythematosus	1.65e-05	0.0045	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	1.6e-05	0.00437	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	1.6e-05	0.00437	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	1.6e-05	0.00436	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	1.59e-05	0.00433	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	1.56e-05	0.00425	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	1.49e-05	0.00407	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	1.49e-05	0.00406	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL2—systemic lupus erythematosus	1.48e-05	0.00404	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	1.48e-05	0.00404	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CCL2—systemic lupus erythematosus	1.47e-05	0.00401	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	1.45e-05	0.00396	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL12—systemic lupus erythematosus	1.44e-05	0.00393	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	1.44e-05	0.00392	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	1.43e-05	0.00389	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	1.42e-05	0.00386	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	1.4e-05	0.00382	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	1.4e-05	0.00381	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	1.39e-05	0.00379	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	1.35e-05	0.00369	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	1.35e-05	0.00367	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TLR9—systemic lupus erythematosus	1.32e-05	0.00359	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TLR9—systemic lupus erythematosus	1.31e-05	0.00356	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	1.29e-05	0.00352	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.28e-05	0.00348	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.27e-05	0.00345	CbGpPWpGaD
Tolvaptan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	1.25e-05	0.00342	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.2e-05	0.00328	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.2e-05	0.00326	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	1.19e-05	0.00325	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CSK—systemic lupus erythematosus	1.17e-05	0.0032	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	1.17e-05	0.00318	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CSK—systemic lupus erythematosus	1.17e-05	0.00318	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	1.16e-05	0.00315	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—JAK1—systemic lupus erythematosus	1.15e-05	0.00313	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	1.13e-05	0.00309	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.1e-05	0.00299	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.09e-05	0.00297	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	1.09e-05	0.00296	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.08e-05	0.00294	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NCF2—systemic lupus erythematosus	1.07e-05	0.00293	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	1.07e-05	0.00292	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.07e-05	0.00292	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—C3—systemic lupus erythematosus	1.07e-05	0.00292	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LYN—systemic lupus erythematosus	1.07e-05	0.00291	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NCF2—systemic lupus erythematosus	1.07e-05	0.0029	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—C3—systemic lupus erythematosus	1.06e-05	0.0029	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.06e-05	0.0029	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LYN—systemic lupus erythematosus	1.06e-05	0.00289	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	1.06e-05	0.00288	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.05e-05	0.00286	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.05e-05	0.00285	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.04e-05	0.00284	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.04e-05	0.00283	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	1.02e-05	0.00279	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCR5—systemic lupus erythematosus	9.96e-06	0.00271	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCR5—systemic lupus erythematosus	9.88e-06	0.00269	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	9.81e-06	0.00267	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	9.74e-06	0.00265	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—C3—systemic lupus erythematosus	9.73e-06	0.00265	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—C3—systemic lupus erythematosus	9.66e-06	0.00263	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	9.42e-06	0.00257	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—F2—systemic lupus erythematosus	9.41e-06	0.00256	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—F2—systemic lupus erythematosus	9.34e-06	0.00254	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	8.98e-06	0.00245	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	8.68e-06	0.00236	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL12—systemic lupus erythematosus	8.58e-06	0.00234	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—F2—systemic lupus erythematosus	8.54e-06	0.00233	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL12—systemic lupus erythematosus	8.52e-06	0.00232	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—F2—systemic lupus erythematosus	8.48e-06	0.00231	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JUNB—systemic lupus erythematosus	8.42e-06	0.0023	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	8.38e-06	0.00228	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JUNB—systemic lupus erythematosus	8.36e-06	0.00228	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	8.22e-06	0.00224	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8e-06	0.00218	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.95e-06	0.00217	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PRL—systemic lupus erythematosus	7.76e-06	0.00211	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PRL—systemic lupus erythematosus	7.7e-06	0.0021	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL2—systemic lupus erythematosus	7.61e-06	0.00207	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL2—systemic lupus erythematosus	7.56e-06	0.00206	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	7.35e-06	0.002	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	7.12e-06	0.00194	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	7.09e-06	0.00193	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.91e-06	0.00188	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.86e-06	0.00187	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	6.53e-06	0.00178	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.33e-06	0.00173	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.29e-06	0.00171	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JAK1—systemic lupus erythematosus	6.21e-06	0.00169	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JAK1—systemic lupus erythematosus	6.16e-06	0.00168	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	6.1e-06	0.00166	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	6.01e-06	0.00164	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCR5—systemic lupus erythematosus	5.88e-06	0.0016	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCR5—systemic lupus erythematosus	5.84e-06	0.00159	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.8e-06	0.00158	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.75e-06	0.00157	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL2—systemic lupus erythematosus	5.75e-06	0.00157	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—C3—systemic lupus erythematosus	5.75e-06	0.00157	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL2—systemic lupus erythematosus	5.71e-06	0.00156	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—C3—systemic lupus erythematosus	5.71e-06	0.00156	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—F2—systemic lupus erythematosus	5.05e-06	0.00138	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—F2—systemic lupus erythematosus	5.01e-06	0.00137	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CD80—systemic lupus erythematosus	4.84e-06	0.00132	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CD80—systemic lupus erythematosus	4.8e-06	0.00131	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL2—systemic lupus erythematosus	4.5e-06	0.00123	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL2—systemic lupus erythematosus	4.47e-06	0.00122	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	4.46e-06	0.00122	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	4.22e-06	0.00115	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TYK2—systemic lupus erythematosus	4.08e-06	0.00111	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TYK2—systemic lupus erythematosus	4.05e-06	0.0011	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOS3—systemic lupus erythematosus	4.01e-06	0.00109	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOS3—systemic lupus erythematosus	3.98e-06	0.00108	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	3.9e-06	0.00106	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	3.71e-06	0.00101	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.56e-06	0.000971	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	3.51e-06	0.000957	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.47e-06	0.000946	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.45e-06	0.000939	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2—systemic lupus erythematosus	3.4e-06	0.000926	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—systemic lupus erythematosus	3.38e-06	0.000921	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2—systemic lupus erythematosus	3.37e-06	0.000919	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—systemic lupus erythematosus	3.36e-06	0.000915	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	3.22e-06	0.000879	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.22e-06	0.000876	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.2e-06	0.000873	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—systemic lupus erythematosus	3.19e-06	0.00087	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.18e-06	0.000867	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EP300—systemic lupus erythematosus	3.05e-06	0.000831	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EP300—systemic lupus erythematosus	3.03e-06	0.000825	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	3.01e-06	0.00082	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	2.98e-06	0.000812	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.89e-06	0.000787	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.87e-06	0.000781	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.65e-06	0.000722	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.63e-06	0.000717	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.02e-06	0.000551	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—systemic lupus erythematosus	2e-06	0.000544	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—systemic lupus erythematosus	1.98e-06	0.00054	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.83e-06	0.0005	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	1.67e-06	0.000455	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	1.05e-06	0.000287	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.03e-06	0.00028	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—systemic lupus erythematosus	9.48e-07	0.000258	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	9.07e-07	0.000247	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	8.29e-07	0.000226	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—EP300—systemic lupus erythematosus	6.9e-07	0.000188	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	6.49e-07	0.000177	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	5.84e-07	0.000159	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	5.59e-07	0.000152	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	5.11e-07	0.000139	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	4.25e-07	0.000116	CbGpPWpGaD
